Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review]

Endocrine Journal

Yasuhiro Ito¹  Hitomi Oda¹  Akira Miyauchi¹ 

[1] Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan

关键词: Papillary microcarcinoma;    Thyroid;    Low-risk;    Active surveillance;   

DOI  :  10.1507/endocrj.EJ15-0637

学科分类：内分泌与代谢学

来源: Japan Endocrine Society

【 摘 要 】

References(24)Cited-By(2)Over 20 years ago, two Japanese institutions initiated an active surveillance policy for papillary microcarcinomas (PMCs) without high-risk features (such as clinical lymph node and distant metastases) and suspected trachea or recurrent laryngeal nerve invasion.Since the most recent American Thyroid Association (ATA) guidelines adopt active surveillance as a therapy option for low-risk PMCs, the number of institutions worldwide carrying out this policy can be expected to increase.However, before adopting an active surveillance strategy, some important clinical questions must be considered.In this review, conceivable clinical questions with our answers based on the present accumulation of low-risk PMC surveillance data are presented.

【 授权许可】

Unknown